We used an In vltro T-lymphoblast clonal prol~ferat~on assay to quantify human IGF-I (hlGF-I)-, human PTH (hPTH)-, human ACTH (hACTH)-, and human TSH (hTSH)-st~mulated growth of human T-cell leukemia v~rus-11-t~ansformed T-lymphoblast cell lines from normal individuals and to elucidate the role of IGF-I as the mediator of hPTH-, hACTH-, and hTSH-induced T-cell growth. Normal T-lymphoblast cell lines respond to hIGF-I in a bimodal fashion. The mean first peak response was 143 i 9.8% above baseline (defined as 100%) occurring at 8 pgiL, and the mean second peak response was 154 i 14.4% occurring at 100 pg/L. Both responses were completely blocked after incubation with aIR-3, an MAb to the IGF-I receptor (by analysis of variance, p = 0.015 between full response curves). After stimulat~on with hPTH, the mean peak clonal response of normal T-lymphoblast cell llnes was 189 ? 7 0%, after incubation wlth aIR-3, the mean peak clonal response wds 108 i-7 9% ( p = 0 0015 between full response curves) The mean peak clonal response of normal T-lymphoblast cell llnes after hACTH stlmulation was 192 i 8 6%, prelncubat~on w~t h aIR-3 reduccd the mean peak clonal response to 94 i 1 2% (17 < 0 0001 between full response cu~ves) Wlth hTSH st~mulat~on, the medn peak clonal response of normal T-lymphoblast cell lines was 167 i 7 0%, after incubat~on with a1R-3, the mean peak clonal response was 94 -C 8 2% ( p = 0 003 between full Iesponse
curves). After stirnulation with hIGF-I, hPTH, hACTH, and hTSH, the mean peak clonal responses of a pygmy Tlymphoblast cell line were 112 i 8.2, 122 t 1.5. 99 i 4.2. and 98 i 5.596, respectively (all p 5 0.0004 between corresponding complete pygmy and normal response curves). These data indicate that hPTH, hACTH, and hTSH stim~llate growth of norrnal huinan T-lymphoblast cell lines through local action of IGF-I, because these effccts can all be blocked by preinci~bation with MAb against the IGF-I receptor. The pygmy T-lymphoblast cell line showed little or no clonal expansion in the presencc of hIGF-I itself, or in response to hPTH. hACTH, or hTSH, further supporting the notion that an intact IGF-I response mcchanism is necessary for the proliferative response to hPTH, hACTH. and hTSH in human T-lymphoblasts. (Pedintr Res 37: 507-511, 1995) Abbreviations hIGF-I, human insulin-like growth factor-I hPTH, human parathyroid hormone hACTH, human adrenocorticotrophic hormone hTSH, human thyroid-stimulating hormone HTLV, human T-cell leukemia virus IGFBP, IGF binding protein GH, growth hormone that the growth promotion is mediated by IGF acting either alone or synergistically with the specific trophic hormone ( I ) . To clarify the role of IGF-I as the mediator of PTH-, ACTH-, and TSH-stimulated tissue growth, we first quantitied the itz vitro clonal proliferation of HTLV-11-transformed Tlymphoblast cell lines established from normal individuals in response to these hormones in the presence and absence of aIR-3, an MAb directed against the IGF-I receptor. The validity of HTLV-11-transformed T-lymphoblast cell lines as a model to study the effects of PTH, ACTH, and TSH is supported by the presence of receptors for each of the hormones on GEFFNER ET AL normal lymphocytes (2-4). We also examined hPTH-, hACTH-, and hTSH-stimulated clonal responsiveness of a T-lymphoblast cell line established from an African Efe pygmy [previously shown to be resistant to the growth-promoting action of both hGH and hIGF-I in this clonal assay (5)], with the hypothesis that there would be lack of response to each hormone if its growth-promoting effect requires the local action of IGF-I. Using this T-lymphoblast cell model, we confirmed that the growth-promoting actions of hPTH, hACTH, and hTSH are mediated by local IGF-I action, and therefore the pygmy T-lymphoblast cell line showed little or no growth responsiveness to these hormones.
METHODS
Patients. T-lymphoblast cell lines were established from six normal adult individuals living in the United States and from one adult male Efe pygmy from central Africa (5, 6). Procurement of blood from the normal subjects was performed after obtaining informed consent, and with the approval of the UCLA Human Subject Protection Committee. Blood from the pygmy was drawn after the nature of the study was explained; verbal consent only could be obtained. At the time of study, the pygmy subject was estimated to be 27 y old, was 143.6 cm tall, weighed 46.5 kg, had a body mass index of 22.6 k g~r n ,~ and had a triceps skinfold thickness of 6.5 mm. The results of plasma studies performed on the pygmy were as follows: IGF-I = 206 pg/L (normal = 1 35-449 pg/L), IGF-I1 = 1 16 pg/L (normal = 288-736 pg/L), IGFBP-3 = 1.9 mg/L (normal = 1.9-4.2 mg/L), and GH binding protein = 38% relative specific binding (normal = 54-159%).
T-lymphoblast transformation. The methodology for HTLV-I1 transformation of peripheral blood lymphocytes has been previously described (7-9). Low-density mononuclear cells (1 X 1 0 5 / m~) , isolated by Ficoll-Hypaque densitygradient separation of 10 mL of blood, were primed overnight with phytohemagglutinin and IL-2 and then cocultivated with an equal number of lethally irradiated (12 000 cGy) latepassage Mo cells (HTLV-11) (10) in Iscove's medium supplemented with 20% fetal bovine serum and IL-2. Virusproducing, immortalized T-lymphoblast cell lines developed in about 4 wk. Cell lines were fed 2 d before clonogenic studies to ensure that all experiments were conducted with cells in an exponential growth phase.
Studies of IGF-I, PTH, ACTH, and TSH responsiveness. Receptor antibody studies. Normal T-lymphoblast cell line clonal responses to hIGF-I, hPTH, hACTH, or hTSH were quantified in the presence or absence of aIR-3, an IgG, MAb against the IGF-I receptor (11) (Oncogene Science, Inc., Manhasset, NY). To ensure the specificity of any blockade induced by aIR-3, normal T-lymphoblast cell line clonal responses to hIGF-I, hPTH, hACTH, and hTSH were also quantified in the presence or absence of E9, an IgG, anti-neutrophil MAb (kindly provided by Dr. Loran Clement, Department of Pediatrics, UCLA). Antibodies were added 1 h before hormones at a final concentration of 5 X 10-5 g/L.
Data analysis. The unstimulated number of T-lymphoblast colonies formed in incubation mixtures without added hormone is defined as 100%. Data are presented as the mean (-+ SEM). Statistical comparisons between basal colony counts were made by t test and between full response curves by repeated measures two-factor analysis of variance.
RESULTS
Normal T-lymphoblast cell lines: hZGF-I, hPTH, hACTH, and hTSH responsiveness in the presence or absence of d R -3 . Mean basal colony counts without added aIR-3 were 82.7 + 12.8 (hIGF-I), 40.1 t 6.4 (hPTH), 41.7 ? 4.7 (hACTH), and 37.6 t 12.4 (hTSH); in the presence of aIR-3, the corresponding mean mean basal colony counts were 79.3 + 12.2, 58.3 t 6.1, 66.8 ? 15.2, and 34.4 -C 12.1 (all p = NS versus no aIR-3), i.e. they were not reduced by aIR-3.
As we have previously reported ( 3 , responsiveness of normal T-lymphoblast cell lines after stimulation with IGF-I was bimodal in nature. The first mean peak clonal response to hIGF-I (mean of three studies using three T-lymphoblast cell lines) was 144 t-9.3% above baseline (defined as 100%) occurring at 8 pg/L, and the mean second peak response was 154 t-14.4% occurring at 100 p g L . After incubation with aIR-3, there was complete obliteration of all IGF-I-induced clonal responsiveness ( p = 0.015 between full response curves) (Fig. 1) .
In response to hPTH, the mean peak clonal response of normal T-lymphoblast cell lines (mean of 18 studies using seven T-lymphoblast cell lines) was 189 ? 7.0% occurring at a hPTH concentration of 18 pmol/L; after incubation with aIR-3, the mean peak clonal response (mean of five studies using five T-lymphoblast cell lines) was significantly blunted to 108 t-7.9% ( p = 0.0015 between full response curves) (Fig. 2) .
After stimulation with hACTH, the mean peak clonal response of normal T-cell lines (mean of seven studies using five T-lymphoblast cell lines) was 192 t 8.6% occurring at a hACTH concentration of 34 pmol/L; after incubation with aIR-3, clonal responsiveness was abolished (mean of four studies using four T-cell lines) with the mean peak response less than baseline [94 i 1.2% (p < 0.0001 between full response curves)] (Fig. 3) .
The mean peak clonal response of normal T-lymphoblast cell lines after stimulation with hTSH (mean of eight studies PTH, ACTH, AND TSH ACTION ON T-CELLS 509 80 1 0 Controls + olR-3 (n=3) I Figure 1 . hIGF-I responsiveness. The mean first peak clonal response of normal T-lymphoblast cell lines to hIGF-I was 144 i 9.3%, and the mean second peak clonal response was 154 ? 14.4%. After preincnbation with aIR-3 MAb to the IGF-I receptor, responsiveness to hIGF-I was completely blocked. Additionally, the pygmy T-lymphoblast cell line showed minimal responsiveness to hIGF-I. In all figures, the unstimulated number of Tlymphoblast colonies (referred to, on the ordinate, as colonies) formed in incubation mixtures without added hormone is defined as 100% and the abscissa represents the concentration of added hormone. The data are presented as the mean t SEM.
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hACTH (pmolIL) Figure 3 . hACTH responsiveness. The mean peak clonal response of normal T-lymphoblast cell lines to hACTH was 192 ? 8.6%. After preincubation with aIR-3, responsiveness to hACTH was completely blunted. Additionally, the pygmy T-lymphoblast cell line showed no responsiveness to hACTH. 
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=obBS ' ' ' "".; ' ' " ""' 1 0 ' ' ' " " " 100 ' ' ' " " " 1000 ' ' " ""I 10000 hPTH (pmol1L) Figure 2 . hPTH responsiveness. The mean peak clonal response of normal T-lymphoblast cell lines to hPTH was 189 t 7.0%. After preincubation with a1R-3, responsiveness to hPTH was significantly blunted. Additionally, responsiveness of the pygmy T-lymphoblast cell line to hPTH was significantly less than that of normal T-lymphoblast cell lines.
using four T-lymphoblast cell lines) was 167 i 7.0% occurring at a hTSH concentration of 3.4 pmol/L; after incubation with aIR-3, the mean peak clonal response (mean of four studies using four T-lymphoblast cell lines) was less than baseline [94 + 8.2% ( p = 0.003 between full response curves)] (Fig. 4 ).
There were no significant differences in peak clonal responses after hormonal stimulation in the presence or absence of E9 anti-neutrophil MAb [hIGF-I: -E9, 142% (first peak) and 144% (second peak), +E9, 148% (first peak) and 144% (second peak); hPTH: -E9, 170%, +E9, 176%; hACTH: -E9, 193%, +E9, 173%; and hTSH: -E9, 174%, +E9, 168%]. . hTSH responsiveness. The mean peak clonal response of normal T-lymphoblast cell lines to hTSH was 167 t 7.0%. After preincubation with aIR-3, responsiveness to hTSH was completely blunted. Additionally, the pygmy T-lymphoblast cell line showed no responsiveness to hTSH.
Pygmy T-lymphoblast cell line: hIGF-I, hPTH, hACTH, and hTSH responsiveness. Mean basal colony counts were 76.8 + 13.4 (hIGF-I), 39.7 + 11 .O (hPTH), 46.1 ? 10.8 (hACTH), and 53.4 + 24.0 (hTSH) ( p = NS versus normal T-lymphoblast cell lines in each case).
The mean first peak clonal response of the pygmy Tlymphoblast cell line after stimulation with hIGF-I was less than baseline, whereas the second mean peak response was 112 i 8.2% occurring at an IGF-I concentration of 100 pg/L (mean of five experiments) (p = 0.0004 between entire pygmy and normal response curves) (Fig. 1) .
After stimulation with hPTH, the mean peak clonal response of the pygmy T-lymphoblast cell line [I22 + 1.5% (mean of seven studies)] was significantly reduced compared to that of normal T-lymphoblast cell lines (p < 0.0001 between entire pygmy and normal response curves) (Fig. 2) . With hACTH stimulation, the mean peak clonal response of the pygmy T-lymphoblast cell line was reduced to less than GEFFNE baseline [99 t 4.2% (mean of four studies)] ( p < 0.0001 between entire pygmy and normal response curves) (Fig. 3) .
The mean peak clonal response of the pygmy T-lymphoblast cell line after stimulation with hTSH was also reduced to less than baseline 198 2 5.5% (mean of three studies)] (11 = 0.0001 between entire pygmy and normal response curves) (Fig. 4) .
DISCUSSION
In this study, we co~ifirrn that hIGF-I induces a bilnodal (two-peak) clonal response by HTLV-11-transformed Tlyrnphoblast cell lines established from normal individuals (5). We also show that physiologic concentrations of hPTH, hACTH, and hTSH stimulate the clonal proliferation of normal T-lymphoblast cell lines and, as deduced from experiments using an MAb against the IGF-I receptor, that this growth stimulation, like that in response to hGH (12), seems to be mediated by local IGF-I. These clonal responses were not significantly altered by preincubation with a similar class of anti-neutrophil MAb, underscoring the specificity of the neartotal blockade of the clonal responses to hPTH, hACTH, and hTSH induced by the IGF-I-receptor MAb. Finally, a Tlymphoblast cell line established from an Efe pygmy is resistant to the growth-promoting action of these four hormones, on the basis of intrinsic resistance of the pygniy T-cell line to IGF-I.
Pretreatment of normal T-lymphoblast cell lines with aIR-3 antibody against the IGF-I receptor blocked clonal responsiveness to all concentrations of IGF-I. This finding was somewhat unexpected inasmuch as we had previously shown (9), using insulin as the ligand, in the presence and absence of aIR-3, that the clonal responses to physiologic insulin concentrations were mediated through the insulin receptor, whereas those to supraphysiologic concentrations of insulin were mediated through the IGF-I receptor because only the latter could be blocked by aIR-3 pretreatment. Thus, to explain our current findings of aIR-3-induced blockade of both physiologic and supraphysiologic hIGF-I responses, we conclude that the former are mediated through the IGF-I receptor, whereas the latter are mediated by hybrid IGF-I-insulin receptors (1 3), the responses of which are blocked by pretreatment with antibody to the IGF-I receptor. Using analagous reasoning, the pygmy T-cell line, which demonstrates no first peak but a small seconcl peak clonal response to IGF-I, may possess a hybrid IGF-1-insulin receptor population capable of responding to IGF-I.
That IGF play a role in the in vitro action of PTH on bone is suggested by studies of neonatal mouse calvariae in which exposure to synthetic bovine PTH (1-12 nmol/L) resulted in a dose-dependent secretion of both IGF-I (5-to 10-fold) and IGF-I1 (1.5-to 2-fold) into conditioned medium (14). Using a cultured rat calvarial model, Canalis et al. (15) showed that synthetic rat PTH-(1-34) (1-100 nmol/L) sti~nulated thymidine incorporation into DNA up to 4.8-fold and increased secretion of IGF-I into the medium 2-to 4-fold; pretreatment of these cells with antibody to IGF-I prevented PTH-stimulated collagen synthesis but not mitogenesis. Synthetic rat PTH-(I-34) ( 0 . 1 1 0 nmol/L) stimulation of parietal bone cultured from 22-d-old rat fetuses resulted in stimulation of IGF-I transcripts by 100-200% after 6 h and in a 40-200% increase in IGF-I concentration in the medium at 24 h (16). Using an iri vivo calf model with catheterized hepatic and portal vessels, Coxam et ul. (17) demonstrated that a synthetic bovine PTH-(1-34) i~ifusioli stimulated hepatic production of IGF-I. Thus, there is ample evidence that PTH regulates IGF-I production and action in vilro and irz vivo.
The role of IGF in adrenocortical tissue growth is incompletely understood. In the rat, adrenal IGF-I and IGF-I1 mRNA decreased during the regrowth period after unilateral adrenalectomy and after ACTH-(1-24) infusion despite a significant increase in gland size (18). 112 viti-o, biosynthetic IGF-I (5.3 nmol/L) and ACTH-(1-24) (55.6 pmol/L) each stimulate steroidogenesis in bovine adrenal fasciculata tissue, with the combination showing synergism. Cell multiplication, however, was unatfected by . Voutilainen and Miller (20) showed that ACTH and dibutyryl-CAMP stimulation of cultured hurnan fetal adrenal tissue resulted ill increased levels of mRNA for both IGF-I1 and cholesterol side-chain-cleavage enzyme, without significantly affecting IGF-I mRNA (20). More recently, Pham-Huu-Trung et ul. (2 1) showed that IGF-I (38.2 pg/L) stimulation of human adrenal tissue resulted in initial increases in production of dehydroepiandrosterone, androstenedione, 1 l -desoxycortisol, and glucocorticoids consistent with activation of 17a-, 2 I-, and 1 1 P-hydroxylase enzyme activities. Lastly, recombinant human IGF-I and IGF-I1 (1000 pgIL) both induced proliferation of hurnan fetal adrenocortical cells by 1.8-to 2-fold and 100-to 200-fold, respectively. In the same study, IGF-I1 rnRNA was found in great abundance in fetal but not in adult adrenocortical cells, with IGF-I mRNA higher in adult than in fetal cells (22) . These findings are consistent with a role for IGF in adrenocortical growth and function in certain species, with ICF-I1 more active in the fetal state and IGF-I more active postnatally. In addition, short-term GH administration (10 d) to children with isolated GH deficiency results in a significant increase in ACTH-stimulated levels of circulating IGF-I (23).
A role for IGF in thyroid growth is suggested by findings using the FRTL-5 rat thyroid cell line, thc cellular proliferation of which is stimulated by IGF, TSH, and thyroid-stimulating immunoglobulins. The mitogenic effects of TSH (1 nmol/L) in this system are blocked by -50% after pretreatment with sm-1.2 MAb to IGF-I (24). Cultured human thyroid follicular cells secrete IGF-l and IGFBP into culture medium in a concentration-dependent fashion after stimulation with purified bovine TSH ( 1 0~' -1 0~ nmol/L) (25). Thus, IGF-I seems to subserve the growth-promoting actions of TSH on the thyroid.
We previously provided three lines of evidence suggesting that IGF-I resistance was present in the currently studied Efe pygmy and may account for his short stature. First, the pygmy Tlymphoblast cell line showed no clonal proliferation in response to direct stimulation with physiologic concentrations of either hGH, hIGF-I, or the hIGF-I analog [Q3,A4,Y 15,LI6]IGF-I (which binds to the type I IGF receptor but not to IGFBP). Second, this pygmy T-lymphoblast cell line, unlike normal HTLV-IItransformed T cells, demonstrated no specific hIGF-I binding (5). Because the growth-promoting effects of hGH in this system are mediated through a local IGF-I loop (12), thcse findings led us to
